Letter to the Editor
Split Viewer
Korean J Hematol 2012; 47(3):
Published online September 25, 2012
https://doi.org/10.5045/kjh.2012.47.3.237
© The Korean Society of Hematology
Prognostic relevance of pericardial effusion in patients with malignant diseases
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Correspondence to : Correspondence to Hyun-Sook Chi. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-4502, hschi@amc.seoul.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
FIGURES
Fig. 1. Overall survival according to pericardial involvement in the malignant disease. The pericardial involvement group had a significantly poorer survival rate than the non-pericardial involvement group (
TABLES
Table 1 Etiological diagnosis and frequency of pericardial involvement in malignant diseases.
a)Angiosarcoma (N=2), cervix cancer (N=1), colorectal cancer (N=4), embryonal carcinoma (N=1), endodermal sinus tumor (N=2), endomertrial cancer (N=1), glottic cancer (N=1), metastatic cancer of unknown origin (N=1), neuroblastoma (N=3), osteosarcoma (N=1), rhabdomyosarcoma (N=1), saivary duct carcinoma (N=1), sarcomatoid carcinoma (N=1), synovial sarcoma (N=1), thyroid cancer (N=2), b)Acute myeloid leukemia (N=2), chronic myelogenous leukemia (N=1), myelodysplastic syndrome (N=1).
REFERENCES
- Gornik, HL, Gerhard-Herman, M, Beckman, JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol, 2005;23;5211-5216.
- Halfdanarson, TR, Hogan, WJ, Moynihan, TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc, 2006;81;835-848.
- Dequanter, D, Lothaire, P, Berghmans, T, Sculier, JP. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Ann Surg Oncol, 2008;15;3268-3271.
- Kim, SH, Kwak, MH, Park, S, et al. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat, 2010;42;210-216.
- Maisch, B, Ristic, A, Pankuweit, S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis, 2010;53;157-163.
PDF
Standard view
Export citation
Share Article
Letter to the Editor
Korean J Hematol 2012; 47(3): 237-238
Published online September 25, 2012 https://doi.org/10.5045/kjh.2012.47.3.237
Copyright © The Korean Society of Hematology.
Prognostic relevance of pericardial effusion in patients with malignant diseases
Tae-Dong Jeong, M.D., Seongsoo Jang, M.D. Ph.D., Chan-Jeoung Park, M.D. Ph.D., and Hyun-Sook Chi, M.D. Ph.D.*
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Correspondence to:Correspondence to Hyun-Sook Chi. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-4502, hschi@amc.seoul.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig 1.
Download
Overall survival according to pericardial involvement in the malignant disease. The pericardial involvement group had a significantly poorer survival rate than the non-pericardial involvement group (
-
Table 1 . Etiological diagnosis and frequency of pericardial involvement in malignant diseases..
a)Angiosarcoma (N=2), cervix cancer (N=1), colorectal cancer (N=4), embryonal carcinoma (N=1), endodermal sinus tumor (N=2), endomertrial cancer (N=1), glottic cancer (N=1), metastatic cancer of unknown origin (N=1), neuroblastoma (N=3), osteosarcoma (N=1), rhabdomyosarcoma (N=1), saivary duct carcinoma (N=1), sarcomatoid carcinoma (N=1), synovial sarcoma (N=1), thyroid cancer (N=2), b)Acute myeloid leukemia (N=2), chronic myelogenous leukemia (N=1), myelodysplastic syndrome (N=1)..
References
- Gornik, HL, Gerhard-Herman, M, Beckman, JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol, 2005;23;5211-5216.
- Halfdanarson, TR, Hogan, WJ, Moynihan, TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc, 2006;81;835-848.
- Dequanter, D, Lothaire, P, Berghmans, T, Sculier, JP. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Ann Surg Oncol, 2008;15;3268-3271.
- Kim, SH, Kwak, MH, Park, S, et al. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat, 2010;42;210-216.
- Maisch, B, Ristic, A, Pankuweit, S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis, 2010;53;157-163.
Previous Article
